Insulet (PODD) Long-Term Investments (2017 - 2023)

Insulet's (PODD) quarterly Long-Term Investments came in at $2.0 million in Q2 2023, up 300.0% on a QoQ basis from $500000.0 in Q3 2020.

Insulet (PODD) Long-Term Investments (2017 - 2023) Analysis & Trends

Insulet (PODD) has 5 years of Long-Term Investments data on file, last reported at $2.0 million in Q2 2023.

Quarterly Long-Term Investments changed N/A year-over-year to $2.0 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $2.0 million (changed N/A YoY) and the FY2019 annual result came in at $58.4 million, down 58.52% from the prior year.
Long-Term Investments rose to $2.0 million in Q2 2023, from $500000.0 in the prior quarter.
In the past five years, Long-Term Investments ranged from a high of $76.8 million in Q1 2019 to a low of $500000.0 in Q3 2020.
A 3-year average of $39.5 million and a median of $44.7 million in 2019 frame the typical range for Long-Term Investments.
The widest YoY moves for Long-Term Investments: up 20.82% in 2020, down 98.39% in 2020.
Tracing PODD's Long-Term Investments over 3 years: stood at $58.4 million in 2019, then plunged by 99.14% to $500000.0 in 2020, then jumped by 300.0% to $2.0 million in 2023.
The last three Long-Term Investments figures came in at $2.0 million (Q2 2023), $500000.0 (Q3 2020), and $23.5 million (Q2 2020), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Abbott Laboratories	199.24 Bn	193.64 Bn	7.27 Bn	1.11 Bn
2	Stryker	128.63 Bn	125.15 Bn	4.50 Bn	-
3	Medtronic	119.19 Bn	109.97 Bn	6.41 Bn	-
4	Boston Scientific	73.51 Bn	72.97 Bn	3.85 Bn	2.25 Bn
5	Edwards Lifesciences	52.11 Bn	47.85 Bn	1.35 Bn	244.10 Mn
6	Dexcom	34.64 Bn	32.70 Bn	830.00 Mn	-
7	GE HealthCare Technologies	34.01 Bn	31.90 Bn	2.18 Bn	-
8	Koninklijke Philips	26.40 Bn	23.08 Bn	4.55 Bn	175.52 Mn
9	Steris	23.14 Bn	22.65 Bn	684.20 Mn	-
10	Insulet	10.35 Bn	9.82 Bn	562.60 Mn	-

Download Data